These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7071910)

  • 1. Rebound gentamicin levels after hemodialysis.
    Bauer LA
    Ther Drug Monit; 1982; 4(1):99-101. PubMed ID: 7071910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of gentamicin serum concentration rebound following hemodialysis.
    Catolico MM; Campbell S; Jones WN; Logan JL
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):46-9. PubMed ID: 3816558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.
    Amin NB; Padhi ID; Touchette MA; Patel RV; Dunfee TP; Anandan JV
    Am J Kidney Dis; 1999 Aug; 34(2):222-7. PubMed ID: 10430966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.
    Sowinski KM; Magner SJ; Lucksiri A; Scott MK; Hamburger RJ; Mueller BA
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):355-61. PubMed ID: 18235142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
    Halpren BA; Axline SG; Coplon NS; Brown DM
    J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting serum gentamicin concentrations in patients undergoing hemodialysis.
    Melby MJ; Heissler JF; Grochowski EC; Stockmar RA
    Clin Pharm; 1985; 4(1):74-7. PubMed ID: 3971687
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gentamicin pharmacokinetics during hemodialysis].
    Takasugi M; Hasegawa O; Soejima M; Yu K; Muta T; Matsuura K; Nakashima Y; Kuroiwa A; Kunifuji Y; Nakamura T
    Nihon Jinzo Gakkai Shi; 1984 Nov; 26(11):1509-19. PubMed ID: 6533375
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of a patient with impaired renal function with gentamicin-PMMA-beads.
    Walenkamp GH; Vree TB
    Arch Orthop Trauma Surg (1978); 1981; 99(2):137-41. PubMed ID: 7316706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.
    Agarwal R; Cronin RE
    Am J Kidney Dis; 1994 Jan; 23(1):47-51. PubMed ID: 8285197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute massive gentamicin intoxication in a patient with end-stage renal disease.
    Lu CM; James SH; Lien YH
    Am J Kidney Dis; 1996 Nov; 28(5):767-71. PubMed ID: 9158219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum gentamicin level after intratracheal application in ventilated patients with normal and reduced kidney function].
    Schulz E; Busse FW; Strasburger C; Herhahn J; Wood WG; Sack K
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1964-7. PubMed ID: 6653435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy.
    Gailiunas P; Dominguez-Moreno M; Lazarus M; Lowrie EG; Gottlieb MN; Merrill JP
    Arch Intern Med; 1978 Nov; 138(11):1621-4. PubMed ID: 309753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Postdialysis Rebound by a New Technology in Hemodialysis.
    Testal AG; Marín DH; Maset RG; Maicas PR; Salvador ISR; Díaz PO; Najera JEF; De Juan ET; Carrera CB
    Ther Apher Dial; 2017 Oct; 21(5):473-477. PubMed ID: 28795535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of ampicillin and gentamicin by hemofiltration.
    Kraft D; Lode H
    Klin Wochenschr; 1979 Feb; 57(4):195-6. PubMed ID: 423486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.
    Dogra GK; Herson H; Hutchison B; Irish AB; Heath CH; Golledge C; Luxton G; Moody H
    J Am Soc Nephrol; 2002 Aug; 13(8):2133-9. PubMed ID: 12138146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
    Fogel MA; Nussbaum PB; Feintzeig ID; Hunt WA; Gavin JP; Kim RC
    Am J Kidney Dis; 1998 Sep; 32(3):401-9. PubMed ID: 9740155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gentamicin concentrations during intratracheal administration.
    Vogel F; Exner M; von Lilienfeld-Toal H; Cattelaens N; Eichelbaum M
    Klin Wochenschr; 1984 May; 62(9):394-8. PubMed ID: 6727280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.